Deborah M. Autor - 21 Nov 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role: Director
Signature: /s/ Denis Butkovic, Attorney-in-Fact
Issuer symbol: AMRX
Transactions as of: 21 Nov 2024
Net transactions value: -$334,074
Form type: 4
Filing time: 25 Nov 2024, 16:26:09 UTC
Previous filing: 19 Nov 2024
Next filing: 08 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMRX	Class A Common Stock	Sale	$56,944	-6,771	-7.2%	$8.41	86,631	21 Nov 2024	Direct	F1
transaction	AMRX	Class A Common Stock	Sale	$277,130	-33,229	-38%	$8.34	53,402	22 Nov 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.38 to $8.47 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
F2	The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 per share to $8.41 per share, inclusive. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.38 to $8.47 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 per share to $8.41 per share, inclusive. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.